Activation of the ACE-2 axis using Ang (1-7) in cancer studies showed promising anticancer effects with disruption of growth-promoting signals as well as decreased angiogenesis, inflammation and metastasis of breast, prostate and hepatocellular carcinoma cells [114,115]. The gene discussed is ACE; the disease is cancer.